ICM
PRPL icon

Invenomic Capital Management’s Purple Innovation PRPL Stock Holding History

Invenomic Capital Management’s Portfolio PRPL Stock Details PRPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$331K – 148
2026
Q1 		$331K Sell
20,000
-5,026
-20% -$87.9K 0.02% 147
2025
Q4 		$432K Sell
25,026
-569
-2% -$11.4K 0.02% 143
2025
Q3 		$598K Sell
25,595
-1,368
-5% -$32K 0.03% 139
2025
Q2 		$492K Sell
26,963
-3,435
-11% -$63.3K 0.03% 144
2025
Q1 		$577K Sell
30,398
-1,409
-4% -$32.5K 0.03% 170
2024
Q4 		$620K Buy
+31,807
New +$720K 0.03% 159

Other funds holding PRPL

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
CA
Crumly & Associates Springfield, Illinois $522M AUM 19.86% 1-Year Est. Return

Invenomic Capital Management's PRPL Position: Q2 2026 in Review

Invenomic Capital Management sold out of Purple Innovation (PRPL) in Q2 2026, closing a stake of 20,000 shares — an estimated $331K sold.

Invenomic Capital Management first reported a position in PRPL in Q4 2024 and held it in 6 quarters. The position peaked at $620K in Q4 2024. 59 funds tracked by Wall St. Rank hold PRPL as of Q2 2026.

  • Invenomic Capital Management reported no remaining Purple Innovation position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 20,000 Purple Innovation shares in Q2 2026, an estimated $331K.
  • Invenomic Capital Management first reported a position in Purple Innovation in Q4 2024 and held it in 6 quarters.
  • Invenomic Capital Management's Purple Innovation position peaked at $620K in Q4 2024.
  • 59 funds tracked by Wall St. Rank held Purple Innovation as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.